246 results on '"Federico, Maurizio"'
Search Results
2. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
3. SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
4. Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs
5. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells
6. Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
7. SARS-CoV-2-Specific CD8 + T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.
8. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?
9. Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles.
10. Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
11. Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production
12. Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
13. Inhibition of HIV-1 Replication in Monocyte-Derived Macrophages by Mycobacterium tuberculosis
14. Virus-Induced CD8+ T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
15. Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
16. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner
17. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages
18. The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
19. Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
20. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
21. Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN
22. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting
23. Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
24. N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
25. MOESM3 of Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
26. HIV-1 Nef Enhances Both Membrane Expression and Virion Incorporation of Env Products: A MODEL FOR THE NEF-DEPENDENT INCREASE OF HIV-1 INFECTIVITY
27. Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
28. Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way
29. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors
30. Engineered exosomes boost the HCV NS3-specific CD8+ T lymphocyte immunity in humans
31. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
32. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
33. The CD8+ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant
34. The ADAR1 editing enzyme is encapsidated into HIV-1 virions
35. Targeting CCL2 inhibits viral DNA accumulation and induces APOBEC3A expression in HIV-infected primary human macrophages
36. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.
37. HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases
38. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1
39. Erratum to: Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
40. miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes
41. HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8+ T Cell-Mediated Immune Response
42. Exosomes from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells License Quiescent CD4 + T Lymphocytes To Replicate HIV-1 through a Nef- and ADAM17-Dependent Mechanism
43. Cell activation and HIV-1 replication in unstimulated CD4+T lymphocytes ingesting exosomes from cells expressing defective HIV-1
44. Targeting CCL2 inhibits viral DNA accumulation and induces APOBEC3A expression in HIV-1 infected primary human macrophages
45. HIV Nef, Paxillin, and Pak1/2 Regulate Activation and Secretion of TACE/ADAM10 Proteases
46. Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence
47. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
48. Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes
49. HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step
50. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.